Top Page
Rentokil Initial
(LSE:RTO)
Rentokil Initial (RTO) vs. iShares MSCI United Kingdom ETF (EWC)
Rentokil Initial Business Overview & Revenue Model
Rentokil Initial Earnings Call Summary
Rentokil Initial Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 5.44B | 5.38B | 3.71B | 2.95B | 2.79B | Gross Profit |
| 4.56B | 1.50B | 977.00M | 714.80M | 653.00M | EBIT |
| 549.00M | 766.00M | 317.00M | 346.50M | 293.80M | EBITDA |
| 1.10B | 1.16B | 747.00M | 676.80M | 586.50M | Net Income Common Stockholders |
| 307.00M | 381.00M | 232.00M | 263.00M | 186.00M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 911.00M | 1.56B | 2.09B | 597.90M | 2.34B | Total Assets |
| 10.55B | 11.13B | 11.92B | 4.32B | 5.84B | Total Debt |
| 4.11B | 4.73B | 5.40B | 1.93B | 3.40B | Net Debt |
| 3.20B | 3.17B | 3.31B | 1.34B | 1.23B | Total Liabilities |
| 6.33B | 7.04B | 7.82B | 3.06B | 4.71B | Stockholders Equity |
| 4.23B | 4.09B | 4.10B | 1.26B | 1.13B |
| Cash Flow | Free Cash Flow | |||
| 463.00M | 526.00M | 410.00M | 403.30M | 391.70M | Operating Cash Flow |
| 678.00M | 737.00M | 600.00M | 563.20M | 544.20M | Investing Cash Flow |
| -373.00M | -416.00M | -1.20B | -441.10M | -327.00M | Financing Cash Flow |
| -752.00M | -361.00M | 1.32B | -417.10M | 62.20M |
Rentokil Initial Technical Analysis
Rentokil Initial Risk Analysis
Rentokil Initial Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £595.45M | 16.67 | 12.12% | 3.77% | 10.34% | 33.59% | |
78 Outperform | £7.50B | 22.21 | 25.35% | 4.31% | 1.94% | 16.26% | |
77 Outperform | £1.79B | 17.58 | 23.48% | 1.80% | 15.25% | 25.57% | |
72 Outperform | £1.97B | 46.71 | 4.71% | 2.90% | -0.68% | -78.93% | |
68 Neutral | £355.32M | 28.39 | 5.32% | 2.93% | -0.65% | ― | |
66 Neutral | £8.81B | 28.60 | 7.38% | 1.69% | 1.13% | -19.48% | |
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% |
Rentokil Initial Corporate Events
Rentokil Initial plc announced that Sally Johnson, a Non-Executive Director, purchased 3,567 ordinary shares of the company at a price of £3.5085 per share on June 2, 2025. This transaction, conducted on the London Stock Exchange, reflects a personal investment by a key managerial figure, potentially signaling confidence in the company’s future performance.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £6.40 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial plc has announced the intended sale of its France Workwear business to H.I.G. Capital for approximately €410 million, with completion expected in Q4 2025. This move allows Rentokil Initial to streamline its operations, focusing more on its core pest control and hygiene & wellbeing sectors, enhancing capital efficiency, and improving cash flow. The transaction aligns with the company’s strategy to concentrate on high-growth markets and reduce capital expenditure, while the proceeds will be used for corporate purposes including deleveraging and investment in growth opportunities.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £6.40 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial plc announced that its CEO, Andy Ransom, acquired 17,753 ordinary shares through the company’s Dividend Reinvestment Plan, with each share priced at £3.4706. This transaction, conducted on the London Stock Exchange, reflects a significant investment by a key executive, potentially indicating confidence in the company’s future performance and stability.
The most recent analyst rating on (GB:RTO) stock is a Buy with a £6.40 price target. To see the full list of analyst forecasts on Rentokil Initial stock, see the GB:RTO Stock Forecast page.
Rentokil Initial PLC held its Annual General Meeting (AGM) on May 7, 2025, where all proposed resolutions were passed. Notably, the re-election of Richard Solomons as a director saw over 20% opposition, prompting the board to engage further with shareholders. The successful passing of resolutions, including those related to director appointments and financial matters, reflects the company’s ongoing commitment to governance and shareholder engagement.
Rentokil Initial has announced the appointment of two new Non-Executive Directors, Leanne Sheraton and Sam Mitchell, effective June 1, 2025. These appointments aim to enhance the company’s board with extensive experience in marketing, brand development, and leadership in North American multi-site businesses. The changes are expected to support Rentokil Initial’s strategic plans, particularly in North America, as the company continues to focus on growth and customer acquisition. Additionally, two current Non-Executive Directors, Linda Yueh and Sarosh Mistry, will be stepping down from the board.
Rentokil Initial plc announced the upcoming retirement of its Chief Executive, Andy Ransom, by the 2026 AGM. Ransom, who has served as CEO for 12 years, has been pivotal in establishing the company as a global leader in pest control. The board, led by Chair Richard Solomons, has initiated the search for a successor. The company is currently prioritizing the turnaround of its underperforming North American business, while maintaining its focus on global market expansion. Ransom will continue to lead these efforts until a new CEO is appointed.
Rentokil Initial has announced the issuance of $750 million in 5.000% Notes due 2030 and $500 million in 5.625% Notes due 2035 through its subsidiary, Rentokil Terminix Funding, LLC. The proceeds will be used to repay a term loan maturing in October 2025 and for general corporate purposes, enhancing the company’s financial flexibility and potentially strengthening its market position.
Rentokil Initial PLC has announced a change in the nature of its holdings due to security lending, with GIC Private Limited crossing a threshold of 6.341478% in voting rights. This adjustment reflects a strategic maneuver in the company’s shareholding structure, potentially impacting its market dynamics and stakeholder interests.
Rentokil Initial PLC reported a modest revenue growth of 1.5% in the first quarter of 2025, with organic revenue growth at 1.8%. Despite challenges in North America due to subdued lead flow, the company remains optimistic about long-term growth, supported by its global reach and diverse customer base. The company is enhancing its growth initiatives through digital lead generation and expanding its satellite branches, while also launching a door-to-door sales program. Internationally, the company saw stronger growth, particularly in Europe, Asia, and the Pacific regions.
Rentokil Initial PLC has been notified of a change in major shareholdings by Independent Franchise Partners, LLP, which now holds 5% of the voting rights in the company. This acquisition of voting rights may influence Rentokil Initial’s shareholder dynamics and potentially impact its strategic decisions, reflecting the ongoing interest and investment in the company’s operations.